Susquehanna International Group, LLP Armata Pharmaceuticals, Inc. Transaction History
Susquehanna International Group, LLP
- $560 Billion
- Q3 2024
A detailed history of Susquehanna International Group, LLP transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 29,786 shares of ARMP stock, worth $62,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,786
Previous 64,012
53.47%
Holding current value
$62,550
Previous $176,000
60.23%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ARMP
# of Institutions
27Shares Held
1.38MCall Options Held
400Put Options Held
17.3K-
Bank Of America Corp Charlotte, NC634KShares$1.33 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA225KShares$473,1020.0% of portfolio
-
Geode Capital Management, LLC Boston, MA107KShares$224,8380.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$210,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX75.4KShares$158,3020.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $75.9M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...